TREATMENT OF CANCER

摘要

There is provided the use of an agent that promotes class III SLRP activity in the manufacture of a medicament for the prevention and/or treatment of cancer. Such medicaments may be used in the treatment of tumours, including avascular tumours. Suitable agents to be used may preferably include the class III SLRPs opticin; epiphycan; or mimecan. The invention also provides a method for the prevention and/or treatment of cancer.